Condiciones de salud que Rubia cordifolia puede ayudar a apoyar.
R. cordifolia root extracts have shown inhibitory activity against Cutibacterium acnes (formerly P. acnes) in vitro, suppressing both bacterial growth and ROS-mediated inflammatory responses. Polyherbal topical formulations containing R. cordifolia have been evaluated in acne vulgaris patients. The anti-acne effect is attributed to antibacterial, anti-inflammatory, and antioxidant constituents including anthraquinones and sitosterol.
Multiple in vitro and in vivo studies confirm R. cordifolia root extracts possess significant antioxidant activity, including DPPH radical scavenging and inhibition of lipid peroxidation (TBARs assay). The constituent purpurin is noted for 'strong antioxidant activity' and the flavonoid/bioflavonoid content provides broad free-radical scavenging capability. Antioxidant activity is listed as a confirmed pharmacological property across peer-reviewed reviews.
R. cordifolia has demonstrated anti-platelet activating factor (PAF) activity, inhibiting PAF-induced platelet aggregation on rabbit platelets in a published PubMed-indexed study (Tripathi et al., Indian J Exp Biol, 1993). Mollugin, a key constituent, also inhibits platelet aggregation triggered by collagen and arachidonic acid. Modern pharmacological reviews confirm 'anti-platelet aggregation' as an established pharmacological activity.
R. cordifolia demonstrates vasodilatory and calcium channel blocking activity in preclinical models, relaxing smooth muscle of the heart and blood vessels analogously to standard calcium channel blocker drugs. Vasodilating properties are listed among its confirmed pharmacological activities in cardiac health research. Traditional Ayurveda also recognizes its use as a vasodilator.
Alcoholic extracts of R. cordifolia have demonstrated antidiabetic activity in alloxan- and STZ-induced diabetic rat models, reducing blood glucose levels. A rat study also showed that R. cordifolia attenuated diabetic neuropathy through antidiabetic and antioxidant mechanisms. Human clinical trials are absent.
R. cordifolia and its primary constituent mollugin have demonstrated significant anti-inflammatory activity in preclinical models, inhibiting TNF-α, IL-6, IL-1β, COX-2, and the NF-κB signaling pathway. Ethanolic and methanolic extracts have shown activity comparable to standard anti-inflammatory drugs in rat models. These effects are mechanistically attributed to mollugin's inhibition of the TAK-1-mediated NF-κB/MAPK axis.
R. cordifolia is widely recognized in both Ayurveda and traditional Chinese medicine for treating eczema. A preliminary open-label clinical study using Manjistha ointment topically for two weeks showed statistically significant improvement (p<0.05) in eczema severity scores, with the greatest benefit in exudation, secondary infection, and itching. The plant is also listed in TCM under dermatological indications including eczema.
R. cordifolia is employed in traditional Asian medicine for abnormal uterine bleeding (AUB), with pharmacological studies demonstrating mechanisms including modulation of the coagulation cascade, fibrinolytic system, and COX-2/cPLA2 inhibition. TCM prescriptions containing R. cordifolia are used clinically for AUB. The hemostatic use is also documented in Tibetan and Ayurvedic traditions.
Rubia cordifolia (common madder/Manjistha) is directly named in the 2018 PubMed systematic review of dietary plants for kidney stone prevention and management as having 'considerable interest based on scientific evidence.' In Ayurvedic medicine it is classified as Ashmaribhedana (stone-breaking) and Mutrala (diuretic), and animal studies confirm reduced calcium oxalate crystal deposition in kidney tissue.
Hydro-alcoholic root extract of R. cordifolia demonstrated significant anti-urolithiasis activity in a rat model, dose-dependently reducing urinary calcium, oxalate, and phosphate excretion abnormalities, and decreasing calcium oxalate crystal deposits in kidney tissue. A related Rubia species (R. tinctorum) has also confirmed anti-urolithiasic effects. Multiple pharmacological reviews cite anti-urolithiasis and anti-nephrotoxicity as confirmed activities.
Rubiadin, a major phytochemical constituent of R. cordifolia, demonstrated hepatoprotective effects comparable to silymarin in a CCl4-induced liver injury rat model, significantly reducing malondialdehyde and preserving glutathione. Additional preclinical studies confirm protection against acetaminophen and CCl4-induced hepatotoxicity. Ayurvedic and Unani traditions also recognize the herb for liver-supportive uses including jaundice.
R. cordifolia has been used clinically in Traditional Asian medicine for primary dysmenorrhea, and network pharmacology studies have revealed its mechanisms in improving blood clotting, circulation, arachidonic acid metabolism, and COX-2/cPLA2 inhibition relevant to menstrual pain. Many prescriptions containing R. cordifolia have been widely used in clinical treatment of primary dysmenorrhea in China.
An ethyl acetate fraction of R. cordifolia root inhibited keratinocyte (HaCaT cell) proliferation in vitro with IC50 of 0.9 µg/ml and induced apoptosis and differentiation in a psoriasis mouse tail model. Traditional Asian medicine also lists psoriasis among its clinical applications, and TCM prescriptions using R. cordifolia have been applied to psoriasis.
R. cordifolia ethanol extract has been evaluated in an adjuvant-induced arthritis (AIA) rat model, with network pharmacology and experimental validation demonstrating reduction of pro-inflammatory mediators TNF-α, IL-1β, and PGE2. The key mechanism involves COX-2 inhibition by alizarin and mollugin, and phospholipase pathway modulation. Traditional use for rheumatism is well-documented across Asian medicine systems.
A 2025 ScienceDirect study investigated R. cordifolia extract in a vitiligo mouse model, demonstrating amelioration of vitiligo via inhibition of the CXCL10/CXCL9/STAT1 signaling pathway—the same pathway targeted by JAK inhibitors clinically used for vitiligo. Uyghur traditional medicine also employs R. cordifolia for vitiligo management.
R. cordifolia hydrogel preparations have demonstrated significant wound-healing activity in animal models, improving wound contraction, reducing wound surface area, and promoting tissue regeneration (p<0.01). Multiple preclinical studies confirm this activity. Topically, the root paste has been used traditionally for wounds and bruises across Ayurveda and Ethiopian medicine.
R. cordifolia is documented across multiple traditional systems—Korean, Indian (Ayurveda), Chinese (TCM), and Unani—as a traditional remedy for arthritis and rheumatism. In traditional Asian medicine, it has been used clinically for arthritis, and one preclinical study documented anti-arthritic properties in an animal model. Limited mechanistic studies suggest COX-2 inhibition as a relevant pathway.
R. cordifolia is listed in multiple authoritative sources as traditionally used for dermatitis and skin ulcers. ScienceDirect notes it is 'popular all over the world for its medicinal uses in skin diseases like eczema, dermatitis and skin ulcers.' The anti-inflammatory anthraquinones are mechanistically relevant, and Ayurveda employs it for inflammatory skin conditions broadly.
In traditional Chinese medicine, plant water decoctions of R. cordifolia are used orally to treat diarrhea; external foot baths with the decoction are also used for children. R. cordifolia is a main ingredient in the Chinese traditional formula 'Er-Xie-Ting granule,' used to treat acute infantile diarrhea. One preclinical study noted antidiarrheal and anti-inflammatory activity in rodents.
R. cordifolia is indicated in Ayurvedic practice for endometriosis, classified under conditions of 'congested uterus' with fixed pain, clots, and amenorrhea. Herbal Reality (a practitioner evidence resource) specifically lists endometriosis among its indications, grounded in its blood-moving and anti-inflammatory Ayurvedic properties. No clinical or preclinical studies on endometriosis specifically have been conducted.
Traditional Tibetan medicine uses R. cordifolia specifically for blood disorders and 'excess heat in the kidneys,' and classical Ayurvedic texts note its use in urinary disorders and blood purification that encompasses uric acid-related conditions. Its diuretic and anti-inflammatory properties are traditionally relevant to gout management.
R. cordifolia is classified in Ayurveda as a 'Varnya' (complexion-enhancing) herb and as 'Varnakrut' (improves skin complexion). A paste made from the root with honey is traditionally applied to remove brown spots, freckles, and skin discoloration. Anthraquinone constituents are proposed to inhibit melanin production, though no controlled clinical studies have confirmed melanin inhibition in humans.
R. cordifolia is traditionally used across Ayurveda, Unani, and Korean medicine to regulate menstrual cycles and address amenorrhea and irregularities. Ayurvedic texts describe its use for 'Yoniruk' (gynecological disorders), and Unani medicine explicitly employs the root for amenorrhea and menstrual irregularities. No clinical trials have evaluated cycle regulation in humans.
R. cordifolia is traditionally used in Ayurveda and Chinese medicine as a hemostatic herb for bleeding conditions. TCM employs it for 'hematorrhea' and renal hemorrhage, and the herb is described as clearing 'heat from the blood' that causes bleeding, which conceptually includes epistaxis. Classical Ayurvedic texts note its use for 'Asra' (blood vitiation) and bleeding conditions.
R. cordifolia is traditionally indicated in Ayurveda for 'Visarpa' (spreading skin diseases, including herpetiform rashes) and is used for itching, rashes, and allergic skin reactions in Ayurvedic and TCM practice. Its anti-PAF activity is mechanistically relevant to allergic urticaria. Ayurvedic texts also note its use for allergic purpura in TCM.
R. cordifolia is recognized in Ayurveda as a 'Varnya' herb enhancing skin complexion and luster, and its constituents (anthraquinones, antioxidant bioflavonoids) are proposed to protect skin from oxidative damage that drives aging. Purpurin exerts anti-inflammatory and skin-calming effects, and the plant is explored in cosmetic formulations for anti-aging benefits. No clinical trials on wrinkle reduction have been conducted.
R. cordifolia is traditionally used externally for skin ulcers, and internally for bleeding ulcers in Ayurvedic and TCM contexts. Mollugin, a major constituent, has demonstrated gastroprotective and antiulcerative properties in pharmacological reviews. Ayurvedic texts describe application to ulcers and wounds, and the herb's astringent, anti-inflammatory, and healing properties underpin this use.
R. cordifolia has documented traditional use for urinary tract disorders in multiple medical systems including Philippine, Unani, and Ayurvedic medicine. Its root decoction is used to treat urinary disorders, and it is classified as 'Meha' (urinary tract disorders) in Ayurveda. Preclinical evidence confirms diuretic and anti-urolithiasis properties.
Volver